KR101747979B1 - 비강 투여를 위한 테트라카인 및 혈관수축제를 포함하는 치과용 마취제 - Google Patents

비강 투여를 위한 테트라카인 및 혈관수축제를 포함하는 치과용 마취제 Download PDF

Info

Publication number
KR101747979B1
KR101747979B1 KR1020117026165A KR20117026165A KR101747979B1 KR 101747979 B1 KR101747979 B1 KR 101747979B1 KR 1020117026165 A KR1020117026165 A KR 1020117026165A KR 20117026165 A KR20117026165 A KR 20117026165A KR 101747979 B1 KR101747979 B1 KR 101747979B1
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
delete delete
tetracaine
subject
nasal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020117026165A
Other languages
English (en)
Korean (ko)
Other versions
KR20120042729A (ko
Inventor
마크 데이비드 콜라
Original Assignee
세인트 레나투스, 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 세인트 레나투스, 엘엘씨 filed Critical 세인트 레나투스, 엘엘씨
Publication of KR20120042729A publication Critical patent/KR20120042729A/ko
Application granted granted Critical
Publication of KR101747979B1 publication Critical patent/KR101747979B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M19/00—Local anaesthesia; Hypothermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020117026165A 2009-04-03 2010-04-02 비강 투여를 위한 테트라카인 및 혈관수축제를 포함하는 치과용 마취제 Expired - Fee Related KR101747979B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16668009P 2009-04-03 2009-04-03
US61/166,680 2009-04-03
PCT/US2010/001002 WO2010114622A1 (en) 2009-04-03 2010-04-02 Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020177005466A Division KR20170026639A (ko) 2009-04-03 2010-04-02 비강 투여를 위한 테트라카인 및 혈관수축제를 포함하는 치과용 마취제

Publications (2)

Publication Number Publication Date
KR20120042729A KR20120042729A (ko) 2012-05-03
KR101747979B1 true KR101747979B1 (ko) 2017-06-15

Family

ID=42164462

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020117026165A Expired - Fee Related KR101747979B1 (ko) 2009-04-03 2010-04-02 비강 투여를 위한 테트라카인 및 혈관수축제를 포함하는 치과용 마취제
KR1020177005466A Ceased KR20170026639A (ko) 2009-04-03 2010-04-02 비강 투여를 위한 테트라카인 및 혈관수축제를 포함하는 치과용 마취제

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020177005466A Ceased KR20170026639A (ko) 2009-04-03 2010-04-02 비강 투여를 위한 테트라카인 및 혈관수축제를 포함하는 치과용 마취제

Country Status (18)

Country Link
US (7) US8580282B2 (enExample)
EP (1) EP2413899B1 (enExample)
JP (3) JP5788864B2 (enExample)
KR (2) KR101747979B1 (enExample)
CN (2) CN102421416B (enExample)
AU (2) AU2010232995C1 (enExample)
BR (1) BRPI1010303A2 (enExample)
CA (1) CA2757032C (enExample)
DK (1) DK2413899T3 (enExample)
EA (1) EA024184B1 (enExample)
ES (1) ES2861064T3 (enExample)
IL (1) IL215489A0 (enExample)
MX (1) MX2011010445A (enExample)
NZ (2) NZ595376A (enExample)
PL (1) PL2413899T3 (enExample)
PT (1) PT2413899T (enExample)
WO (1) WO2010114622A1 (enExample)
ZA (2) ZA201107011B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5788864B2 (ja) 2009-04-03 2015-10-07 セイント レナタス， エルエルシー 鼻腔内投与用のテトラカインおよび血管収縮薬を含む歯科用麻酔剤
NZ629475A (en) 2012-09-28 2017-03-31 St Renatus Llc Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
WO2015103450A1 (en) * 2014-01-01 2015-07-09 Real Time Imaging Technologies, Llc Improved local anesthetic solution for dental and/or contrast media use
AU2015277272A1 (en) * 2014-06-16 2017-01-12 Loewi LLC Methods of anesthetizing nerve tissue in the trigeminal nerve pathway and medical uses thereof
EA201791448A1 (ru) * 2014-12-23 2017-11-30 СТ. РЕНАТУС, ЭлЭлСи Анестетик на основе тетракаина
WO2016115117A1 (en) 2015-01-12 2016-07-21 Real Time Imaging Technologies, Llc Low-dose x-ray imaging system
US10039830B2 (en) * 2016-03-04 2018-08-07 Cetylite Industries, Inc. Topical anesthetic composition
WO2017210390A1 (en) * 2016-06-01 2017-12-07 St. Renatus, Llc Intranasal dental anesthetic
CA3122363A1 (en) 2018-12-19 2020-06-25 Nortic Holdings Inc. Therapeutic composition of intranasal lidocaine
CN111494310A (zh) * 2020-04-29 2020-08-07 周晓玲 一种局部麻醉药物的制备及使用方法
EP4648760A1 (en) * 2023-01-13 2025-11-19 Smilanich, Michael D. Composition for local anesthesia and uses thereof
GB2628149A (en) * 2023-03-16 2024-09-18 Lee Nathaniel Wurie Nasal spray for performing sphenopalatine ganglion block

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3832460A (en) * 1971-03-19 1974-08-27 C Kosti Anesthetic-vasoconstrictor-antihistamine composition for the treatment of hypertrophied oral tissue
US5209724A (en) 1988-04-11 1993-05-11 Dhaliwal Avtar S Composite anesthetic article and method of use
AU4673993A (en) 1992-07-28 1994-02-14 Procter & Gamble Company, The Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether
US5854269A (en) 1993-11-19 1998-12-29 Schering-Plough Healthcare Products, Inc. Nasal spray compositions
US5585398A (en) 1994-07-15 1996-12-17 Ernst; Amy A. Topical anesthetic comprising lidocaine, adrenaline, and tetracaine, and its method of use
US6075059A (en) 1999-02-24 2000-06-13 The Ohio State University Compositions for dental anesthesia
US20040131665A1 (en) * 1999-10-22 2004-07-08 Wepfer Scott T. Topical anesthetic formulation
US6413499B1 (en) * 2000-01-06 2002-07-02 Bryan M. Clay Methods and kits for maxillary dental anesthesia by means of a nasal deliverable anesthetic
US20040045546A1 (en) 2002-09-05 2004-03-11 Peirce Management, Llc Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
JP4591746B2 (ja) * 2002-12-03 2010-12-01 大正製薬株式会社 難溶性抗ウイルス成分含有水溶性外用剤組成物
ES2223277B1 (es) * 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.
WO2005065696A1 (en) 2004-01-01 2005-07-21 Panacea Biotec Ltd. Pharmaceutical compositions comprising an extract of euphorbia prostrata
US20060052305A1 (en) * 2004-05-10 2006-03-09 Nastech Pharmaceutical Company Inc. Method of treating osteoporosis using intranasal parathyroid hormone
WO2007050543A2 (en) 2005-10-24 2007-05-03 Collegium Pharmaceutical, Inc. Topical pharmaceutical foam composition
US9252862B2 (en) 2008-09-17 2016-02-02 Qualcomm Incorporated MIMO preamble for initial access with an unknown number of transmit antennas
JP5788864B2 (ja) * 2009-04-03 2015-10-07 セイント レナタス， エルエルシー 鼻腔内投与用のテトラカインおよび血管収縮薬を含む歯科用麻酔剤

Also Published As

Publication number Publication date
AU2015242984B2 (en) 2017-09-14
CN102421416B (zh) 2014-05-28
AU2010232995C1 (en) 2016-01-28
EA201171215A1 (ru) 2012-07-30
AU2010232995A1 (en) 2011-10-20
US10420750B2 (en) 2019-09-24
US20170326112A1 (en) 2017-11-16
CA2757032C (en) 2022-06-07
US20170326111A1 (en) 2017-11-16
IL215489A0 (en) 2011-12-29
JP2015034167A (ja) 2015-02-19
CN102421416A (zh) 2012-04-18
KR20120042729A (ko) 2012-05-03
US20170319547A1 (en) 2017-11-09
US20160184269A1 (en) 2016-06-30
US9308191B2 (en) 2016-04-12
JP5788864B2 (ja) 2015-10-07
US20140234421A1 (en) 2014-08-21
KR20170026639A (ko) 2017-03-08
CN103932973B (zh) 2017-08-11
NZ595376A (en) 2013-09-27
AU2010232995B2 (en) 2015-07-16
PL2413899T3 (pl) 2021-09-20
BRPI1010303A2 (pt) 2016-03-15
EA024184B1 (ru) 2016-08-31
CN103932973A (zh) 2014-07-23
CA2757032A1 (en) 2010-10-07
US10456377B2 (en) 2019-10-29
ZA201107011B (en) 2014-03-26
EP2413899B1 (en) 2021-01-27
US20120039960A1 (en) 2012-02-16
JP2012522783A (ja) 2012-09-27
NZ612063A (en) 2015-02-27
WO2010114622A1 (en) 2010-10-07
ZA201309321B (en) 2016-07-27
DK2413899T3 (da) 2021-04-19
AU2015242984A1 (en) 2015-11-05
PT2413899T (pt) 2021-03-30
US8580282B2 (en) 2013-11-12
US20200268715A1 (en) 2020-08-27
MX2011010445A (es) 2012-01-19
JP2017031226A (ja) 2017-02-09
US9855247B2 (en) 2018-01-02
ES2861064T3 (es) 2021-10-05
EP2413899A1 (en) 2012-02-08

Similar Documents

Publication Publication Date Title
KR101747979B1 (ko) 비강 투여를 위한 테트라카인 및 혈관수축제를 포함하는 치과용 마취제
CN101754766A (zh) 疼痛控制的方法
KR20170102892A (ko) 테트라카인계 마취제
US20240238224A1 (en) Composition for local anaesthesia and uses thereof
HK1165296B (en) Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
US20170360718A1 (en) Intranasal dental anesthetic

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

PX0701 Decision of registration after re-examination

St.27 status event code: A-3-4-F10-F13-rex-PX0701

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20230610

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20230610